164 related articles for article (PubMed ID: 31541523)
21. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
[TBL] [Abstract][Full Text] [Related]
22. Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.
Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
Biomed Pharmacother; 2017 Jun; 90():437-445. PubMed ID: 28391165
[TBL] [Abstract][Full Text] [Related]
23. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
Sun QS; Luo M; Zhao HM; Sun H
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.
Liu D; Huang Y; Zeng J; Chen B; Huang N; Guo N; Liu L; Xu H; Mo X; Li W
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1629-40. PubMed ID: 21861134
[TBL] [Abstract][Full Text] [Related]
26. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
27. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
28. Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways.
Kim HJ; Choi JW; Ree J; Lim JS; Lee J; Kim JI; Thapa SB; Sohng JK; Park YI
Life Sci; 2022 Jul; 300():120495. PubMed ID: 35341826
[TBL] [Abstract][Full Text] [Related]
29. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
30. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.
Yu X; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
J Natl Cancer Inst; 2002 Apr; 94(7):504-13. PubMed ID: 11929951
[TBL] [Abstract][Full Text] [Related]
31. Rosemary extract reduces Akt/mTOR/p70S6K activation and inhibits proliferation and survival of A549 human lung cancer cells.
Moore J; Megaly M; MacNeil AJ; Klentrou P; Tsiani E
Biomed Pharmacother; 2016 Oct; 83():725-732. PubMed ID: 27470574
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells.
Chen J; Bi H; Hou J; Zhang X; Zhang C; Yue L; Wen X; Liu D; Shi H; Yuan J; Liu J; Liu B
Cell Death Dis; 2013 Sep; 4(9):e814. PubMed ID: 24071646
[TBL] [Abstract][Full Text] [Related]
33. circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p/CDKL1 signaling pathway.
Lu M; Xiong H; Xia ZK; Liu B; Wu F; Zhang HX; Hu CH; Liu P
Cancer Gene Ther; 2021 Apr; 28(3-4):197-211. PubMed ID: 32778770
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract][Full Text] [Related]
35. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
Chen Y; Yang S; Zhou H; Su D
Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
[TBL] [Abstract][Full Text] [Related]
36. TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.
Wang Q; Gao G; Zhang T; Yao K; Chen H; Park MH; Yamamoto H; Wang K; Ma W; Malakhova M; Bode AM; Dong Z
Cancer Res; 2018 Jul; 78(14):3982-3994. PubMed ID: 29748372
[TBL] [Abstract][Full Text] [Related]
37. Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer.
Chen S; Gu T; Lu Z; Qiu L; Xiao G; Zhu X; Li F; Yu H; Li G; Liu H
Respir Res; 2019 Sep; 20(1):202. PubMed ID: 31481083
[TBL] [Abstract][Full Text] [Related]
38.
An W; Zhang Y; Lai H; Zhang Y; Zhang H; Zhao G; Liu M; Li Y; Lin X; Cao S
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730618
[No Abstract] [Full Text] [Related]
39. Biochemical and computational evaluation of Triptolide-induced cytotoxicity against NSCLC.
Hamdi AM; Jiang ZZ; Guerram M; Yousef BA; Hassan HM; Ling JW; Zhang LY
Biomed Pharmacother; 2018 Jul; 103():1557-1566. PubMed ID: 29864943
[TBL] [Abstract][Full Text] [Related]
40. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]